Mohammed Shabbir Ezzi

Advancing Health Equity in Global Oncology: A Collaborative Academic-Cancer Society-Industry Program to Address Health Disparities in Sub-Saharan Africa

Kenneth Wing Merrell, Ben Kamdem-Talom, Hannah Ayettey Anie, Christine Wekesa et autres

PURPOSE: Cancer care capacity in sub-Saharan Africa (SSA) is constrained by late diagnosis and limited treatment access. Few funding mechanisms support innovative, locally led programs to address these challenges. A collaborative initiative was developed to strengthen oncology care through quality improvement (QI) …

us, Ghana, Kenya, Zimbabwe, Afrique du Sud, Nigéria, Cameroun, ca (code pays fourni par la source)

Arabic YouTube Videos on Sleeve Gastrectomy: A Reproducible Web Scrapping Study

Mohammed Shabbir Ezzi, Basem A. Zogel, Alwaleed Hakami, Samar M. Alfaifi et autres

Background: Patients’ awareness, attitude, and expectations play a vital role in bariatric surgical practice. Social media platforms, such as YouTube, have emerged as promising tools for providing patient education and support. Our aim was to assess the nature, informative value, and parameters …

sa, Égypte (code pays fourni par la source)

Clinical Presentation of Chronic Myeloid Leukaemia and Its Correlation with Haematological Parameters in Kenya

Nicholas Anthony Othieno-Abinya, Joseph David Macharia Maina, Angela McLigeyo, Andrew Oluoch Odhiambo et autres

Background: Chronic myeloid leukaemia (CML) is commonly asymptomatic and is discovered incidentally in up to about 50% of patients in chronic phase, due to abnormally high white blood cell (WBC) counts. Commonest symptoms include fatigue and abdominal pain/discomfort, while some patients present …

Kenya, it (code pays fourni par la source)

Factors associated with occurrence of acute leukemias and myelodyplastic neoplasms as seen at the Kenyatta National Hospital, Nairobi, Kenya.

Nicolas Anthony Othieno-Abinya, Joseph David Macharia Maina, Jamila Rajab, Mohammed Ahmed Kalebi et autres

e18502 Background: Acute leukaemias-acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL) usually carry poor prognosis. Myelodysplastic neoplasms (MDNs) run variable courses. Depending on the risk category some tend to terminally transform into AML. Known risk factors include exposure to radiation, tobacco, …

Kenya, it, us (code pays fourni par la source)

Assessing capabilities of Africa hepatopancreatobiliary cancer consortium member institutions for research and the clinical management of hepato-pancreato-biliary cancers

Mary E. Cooley, Hailemichael Desalegn, John WS Devar, Solomon O. Rotimi et autres

Report of a chronic myeloid leukemia registry in a low-and middle-income setting.

Nicolas Anthony Othieno-Abinya, Walter Otieno Mwanda, Miriam Claire Mutebi, Mary Flaviane Nyangasi et autres

7054 Background: Treatment of chronic myeloid leukaemia (CML) in Kenya has been supported since the year 2002 by a collaboration between the Max Foundation and Novartis Pharmaceuticals in the Glivec International Patient Assistance Program (GIPAP). In November 2020 this was transitioned to …

Kenya (code pays fourni par la source)

Treatment failure with first line imatinib for patients with chronic myeloid leukaemia in Kenya vs high-income countries.

Angela McLigeyo, Nicolas Abinya, Sitna Ali Mwanzi, Peter Omondi Oyiro et autres

e19068 Background: Chronic Myeloid Leukemia (CML) occurs in all age groups but predominantly in adults. The disease pathogenesis is typified by the presence of BCR-ABL fusion protein coded for by BCR-ABL gene, a product of reciprocal translocation between the long arms of …

Kenya (code pays fourni par la source)

Efficacy and safety of ponatinib in management of chronic myeloid leukaemia: Experience from Kenya.

Nicolas Anthony Othieno-Abinya, Angela McLigeyo, Peter Omondi Oyiro, Andrew Oluoch Odhiambo et autres

e19067 Background: BCR-ABL tyrosine kinase inhibitors imatinib, nilotinib, bosutinib, and dasatinib, are used upfront in the management of chronic myeloid leukaemia (CML). In terms of resistance, ponatinib is the most potent tyrosine kinase inhibitor used in CML. It is however not used …

Kenya (code pays fourni par la source)

Baseline blood count levels increase odds of cytopenia among CML patients in Kenya: a case control study

Angela McLigeyo, Jamilla Rajab, Peter Omondi Oyiro, Mohammed Shabbir Ezzi et autres

Abstract Background Imatinib is the gold standard for the treatment of all phases of Philadelphia positive Chronic Myeloid Leukemia (CML). During treatment, patients may develop cytopenia. We aimed to study the baseline characteristics and factors associated with cytopenia at a Nairobi Hospital. …

Kenya (code pays fourni par la source)

Additional file 1 of Baseline blood count levels increase odds of cytopenia among CML patients in Kenya: a case control study

Angela McLigeyo, Jamilla Rajab, Peter Omondi Oyiro, Mohammed Shabbir Ezzi et autres

Additional file 1.

Impact of COVID-19 on Cancer Care Delivery in Africa: A Cross-Sectional Survey of Oncology Providers in Africa

Yehoda M. Martei, Tara J. Rick, Temidayo A. Fadelu, Mohammed Shabbir Ezzi et autres

PURPOSE: The COVID-19 pandemic has disrupted cancer care globally. There are limited data of its impact in Africa. This study aims to characterize COVID-19 response strategies and impact of COVID-19 on cancer care and explore misconceptions in Africa. METHODS: We conducted a …

us, nl, Kenya, ca, Afrique du Sud, Ghana (code pays fourni par la source)

Baseline blood count levels increase odds of cytopenia among CML patients in Kenya: a case control study

Angela McLigeyo, Jamilla Rajab, Peter Omondi Oyiro, Mohammed Shabbir Ezzi et autres

Abstract Background Imatinib is the gold standard for the treatment of all phases of Philadelphia positive Chronic Myeloid Leukemia (CML). During treatment, patients may develop cytopenia. We aimed to study the baseline characteristics and factors associated with cytopenia at a Nairobi Hospital. …

Kenya, np (code pays fourni par la source)